Cori Clinical

The page provides delivery history with external benchmarks, pricing based on actual outcomes, and risk assessments for new trials.

A small team runs the study the way a large one does. Design, documents, submissions and amendments from the living blueprint of your clinical trial, with every decision traceable.

Cori creates a dynamic blueprint for clinical trials, generating feasibility studies, designs, risks, bids, budgets, and regulatory packages.

ISO/IEC 27001 certified, GDPR and EU AI Act compliant. Every trial runs on its own, in your region, with every action logged in a trail nobody can quietly edit.

Cori uses AI to assist with trial documents while retaining decision-making for the user’s team.

Funding will accelerate Cori Clinical's product development, expand delivery capacity and support growth across its clinical, engineering and commercial teams, including newly appointed Chief Clinical Officer Dr Emma Ogburn.

Cori automates regulatory and administrative tasks for clinical trials while maintaining compliance and control.

The page offers a 30-minute session focused on a user’s own study.

The page explains how to contact Cori Clinical support and what information to provide for efficient resolution.

AI for clinical trials. Cori helps CROs and sponsors move from trial design to first participant in, connecting decisions, documents and costs in one workspace.

The page outlines Cori Clinical’s policies for collecting, using, disclosing, and protecting personal information.

The terms governing access to and use of the Cori Clinical platform, related websites, applications, APIs and documentation.

Cori Clinical secures €3.56 million in seed funding to develop AI tools for validating clinical-trial protocols against regulatory standards. The London-based startup leverages AI to automate compliance checks in trial design. Breega leads the investment round.

Oct 2026PomegraNews article

Cori Clinical secures $4 million in funding to reduce expenses associated with clinical trial protocols. The company focuses on streamlining processes in clinical research to improve efficiency and accessibility for trial sponsors.

Oct 2026WorkNation NewsNews article

Cori Clinical secures £3 million in seed funding led by Breega, with Enzo Ventures joining as an investor. The healthtech startup allocates the capital toward expanding its team, scaling delivery operations, and enhancing its AI-powered platform for clinical trial design and regulatory submissions. The company focuses on streamlining processes in drug development workflows.

Oct 2026nstartup.meNews article

Cori Clinical raises **$4.0 million** in seed funding to advance its AI-driven platform, which streamlines clinical trial start-up processes. The startup offers an intelligence layer that consolidates trial insights and organizational experience into a unified workspace. Investors include Breega, Enzo, HEARTFELT, Together Ventures, and Bynd, supporting its mission to reduce delays in healthcare innovation.

Oct 2026SignalbaseNews article